The Severity Assessment Model for AECOPD With Combination of Disease and Syndrome
April 9, 2025 updated by: Henan University of Traditional Chinese Medicine
Construction and Evaluation of the Severity Assessment Model for AECOPD With Combination of Disease and Syndrome Based on Machine Learning
The establishment of the AECOPD severity assessment model can quickly and accurately evaluate the condition, which is of great significance for standardizing diagnosis and treatment, improving efficacy, and improving prognosis.
At the same time, it can provide ideas and methods for the research of disease assessment models in related fields.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
Accurate assessment of the condition is the prerequisite and basis for standardized clinical treatment.
Traditional Chinese medicine has shown good efficacy and advantages in treating AECOPD, but currently there is no ideal standard for judging the severity, nor is there an accurate, practical, and TCM specific disease assessment tool.
Therefore, this project integrates multidimensional variables of traditional Chinese and Western medicine, and intends to conduct research on the construction of a disease syndrome combined AECOPD disease assessment model through literature review, expert consultation, clinical investigation, and machine learning algorithms, and establish preliminary grading standards for the severity of AECOPD disease.
Ultimately, it provides ideas and methods for the rapid and accurate assessment of AECOPD, standardized diagnosis and treatment, improved efficacy, improved prognosis, and research on disease assessment models in related fields.
Study Type
Observational
Enrollment (Estimated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hailong H Zhang, doctor
- Phone Number: +86-0371-66248624
- Email: zhanghailong6@126.com
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China, 450000
- The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
-
Contact:
- Hailong H Zhang, doctor
- Phone Number: +86-0371-66248624
- Email: zhanghailong6@126.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Description
Inclusion Criteria:
- Meets AECOPD diagnostic criteria.
- Voluntarily participate in the research and sign the consent form
Exclusion Criteria:
- Individuals with severe mental disorders and cognitive impairments who are unable to communicate normally
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
AECOPD Patients
|
Diagnosis and severity grading of AECOPD disease, as well as assessment of traditional Chinese medicine syndromes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Investigation Questionnaire on Influencing Factors of the Severity of AECOPD
Time Frame: 24 hours
|
The influencing factors of the severity of AECOPD were evaluated through clinical investigation questionnaires. Questionnaire Title: Clinical Investigation Questionnaire on Influencing Factors of AECOPD Severity. The questionnaire adopts the scoring method, which is divided into "very unimportant", "not important", "average", "important" and "very important", and the corresponding values are assigned as 1, 2, 3, 4 and 5 respectively.The higher the score is, the more significant the result is. |
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 1, 2025
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
January 27, 2025
First Submitted That Met QC Criteria
April 6, 2025
First Posted (Actual)
April 9, 2025
Study Record Updates
Last Update Posted (Actual)
April 11, 2025
Last Update Submitted That Met QC Criteria
April 9, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Model for AECOPD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.